Larvol Delta - Study-of-SGC001-Injection-for-Predicted-Severe-Acute-Pancreatitis-to-Assess-Safety-Tolerability-and-Preliminary-Efficacy

dukiprubart (SGC001) - Beijing Sungen Biomedical Technology

http://clinicaltrials.gov/ct2/show/NCT07803965

Sep 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next